Lataa...
Luminescent ruthenium(II) polypyridyl complexes acted as radiosensitizer for pancreatic cancer by enhancing radiation-induced DNA damage
Background: Pancreatic cancer is a highly lethal malignancy which ranks 4th most common cause of cancer death in US and 6th in China. Novel drugs are required to improve the survival and prognosis of patients. Methods: Ruthenium(II) complexes with variation number of DIP ligand were synthesized and...
Tallennettuna:
| Julkaisussa: | Theranostics |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Ivyspring International Publisher
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6771246/ https://ncbi.nlm.nih.gov/pubmed/31588242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.34015 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|